成都正民德思生物科技有限公司致力于成為中國與世界生物技術(shù)產(chǎn)業(yè)的紐帶，以務(wù)實的原則將歐洲高科技、高質(zhì)量、高效能的產(chǎn)品引進中國。正民德思從2013年起至今，作為生物制藥和體外診斷領(lǐng)域相關(guān)產(chǎn)品的供應(yīng)商，秉承“為客戶增值”的企業(yè)價值觀提供優(yōu)質(zhì)的服務(wù)，通過對合作伙伴、客戶及社會的契約責(zé)任的高度重視，已積累與中國、德國、西班牙、奧地利、美國、芬蘭等眾多知名生命科學(xué)企業(yè)、生物技術(shù)公司、制藥公司、科研院校的合作經(jīng)驗，并獲得合作伙伴和客戶的高度認可并保持穩(wěn)固的戰(zhàn)略合作關(guān)系，互相支持、共同發(fā)展。
 
目前，成都正民德思生物科技有限公司作為德國蛋白純化產(chǎn)品生產(chǎn)商Cube Biotech中國獨家總代理、西班牙生物磁性分離設(shè)備制造商SEPMAG中國獨家總代理、西班牙工業(yè)級大規(guī)模蛋白純化填料制造商ABT中國獨家總代理、德國色譜制造商Applicrom中國獨家總代理、西班牙免疫診斷試劑研發(fā)服務(wù)商Pragmatic Diagnostics中國獨家戰(zhàn)略合作方，在成都成立中國總部辦事處，全權(quán)負責(zé)上述合作伙伴在中國地區(qū)的營銷事務(wù)、銷售及售后服務(wù)等所有工作。
 
正民德思通過創(chuàng)新的國際商業(yè)運作理念，打造出一支高素質(zhì)的團隊，推進穩(wěn)步的發(fā)展戰(zhàn)略，已實現(xiàn)了品牌、市場、團隊、技術(shù)、管理國際化標(biāo)準(zhǔn)。同時，正民德思擁有來自麻省理工學(xué)院、海德堡大學(xué)、奧地利科學(xué)院等知名海外科研院所生物科技制藥領(lǐng)域的專家教授作為技術(shù)顧問團隊。
 

Chengdu Zenmindes Biotech Co., Ltd. aims to be the link between China and the world in the biotechnology industry. Zenmindes aspires to introduce European high-tech, high-quality, and high-efficiency products into China and strives to achieve mutual benefit with each side.
Zenmindes also participates in cooperation services for international life science projects. Presently, Zenmindes is an enthusiastic supplier of products related to Biopharmaceutical and In Vitro Diagnosis. By emphasizing the contractual responsibilities to partners, customers, and the society as a whole, Zenmindes has obtained extensive cooperation experience with numerous world-leading life science companies, as well as research and educational institutions, has been highly recognised by cooperative partners in their long-term stable strategic cooperation relations that have been long-term established.

Upholding innovative philosophies in international business operations, Zenmindes has developed a highly-qualified team to boost its solid development strategies. In the meantime, it has progressively brought its brand, market, team, technologies, and management into line with international standards, committing to becoming a bridge linking global high-end biotech products with the bioscience market in China.